Research & Development
PD-Rx's board reports USD2.20 per share dividend
7 December 2018 -

The board of directors of PD-Rx Pharmaceuticals Inc (OTC:PDRX) Thursday declared its onetime dividend of USD2.20 per share of its stock.

Shareholders of record at the close of business as of 30 November 2018 will receive the dividend on 12 December 2018.

According to the company, it offers pharmaceutical and management strategies to the healthcare industry,with focus on new products, solid business partners and the specialised segment of the pharmaceutical industry.

As a licensed FDA manufacturer and packager, the company offers a full spectrum of medications, specialised services, proprietary products and prepackaged medications that are viewed by patient, insurance payers and healthcare providers as a progressive and responsive practice.

Login
Username:

Password:


Related Headlines